Kura Oncology

About Kura Oncology

Kura Oncology is dedicated to realizing the promise of precision oncology by developing novel cancer therapeutics that target cancer cells selectively. Their mission is to help patients with cancer lead better, longer lives by addressing high unmet needs and investigating therapies in combination with standards of care for durable remissions.

Products & Services

Ziftomenib:A precision medicine targeting menin inhibitors, part of their oncology pipeline.

Tipifarnib:A precision medicine targeting farnesyltransferase inhibitors for cancer treatment.

Darlifarnib (KO-2806):Another precision medicine in their pipeline focused on farnesyltransferase inhibitors.

Specialties

Precision Oncology Cancer Therapeutics Novel Biomarkers Overcoming Resistance in Cancer Treatment Acute Leukemias Head and Neck Cancer

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Milestone Payment T: - FT: Milestone Payment	A: 30000000 MR: - FA: 30 million FAN: 30000000	D: 2025-11-03 FD: 2025-11-03	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 150000000 MR: - FA: 150 million FAN: 150000000	D: 2024-01-24 FD: 2024-01-24	3 investors
3	RT: Public Offering T: - FT: Public Offering	A: 100000000 MR: - FA: approximately $100 million FAN: 100000000	D: 2023-06-14 FD: 2023-06-14	7 investors
4	RT: Public Offering T: - FT: Public Offering	A: 100000000 MR: - FA: 100,000,000 FAN: 100000000	D: 2023-06-13 FD: 2023-06-13	7 investors

Milestone Payment Latest

2025-11-03

$30.0M

1 investor (Pro only)

Private Placement 2024-01-24

$150.0M

Public Offering 2023-06-14

$100.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Troy Wilson

President and Chief Executive Officer

LinkedIn (Pro only)

T

Teresa Bair

Chief legal officer

F

Francis Burrows

Chief Scientific Officer

K

Kathleen Ford

Electrical Engineer

M

Mollie Leoni

Chief Medical Officer

B

Brian Powl

Chief Commercial Officer

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Kura Oncology Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised